Literature DB >> 16412049

Novel roles of osteopontin and CXC chemokine ligand 7 in the defence against mycobacterial infection.

V Khajoee1, M Saito, H Takada, A Nomura, K Kusuhara, S-I Yoshida, Y Yoshikai, T Hara.   

Abstract

Granulocyte-macrophage colony-stimulating factor (GM-CSF)-induced human monocyte-derived macrophage (GM-Mphi) or macrophage CSF (M-CSF)-induced human monocyte-derived Mphi (M-Mphi) are distinct in terms of the resistance to Mycobacterium tuberculosis. To elucidate the role of molecules involved in the functional differences between these Mphis, we investigated the gene expression profiles using microarray. After culture of CD14+ monocytes with CSFs, Mphis were cultured with or without bacillus Calmette-Guérin (BCG) (GM-Mphi-BCG and M-Mphi-BCG). The gene expression profiles from these cells were compared. Chemokines highly expressed in M-Mphis were selected and evaluated for anti-mycobacterial activity and superoxide production. FN1 and FCGR2B were the most up-regulated genes in GM-Mphi and M-Mphi, respectively. After stimulation with BCG, three chemokine genes (Osteopontin (SPP1), CXC chemokine ligand 7 (CXCL7) and CC chemokine ligand 11 (CCL11)) were highly expressed in M-Mphi-BCG when compared to those in GM-Mphi-BCG. A significantly increased resistance to M. tuberculosis H37Ra was observed after the stimulation of GM-Mphi with SPP1 or CXCL7. Superoxide production levels of SPP1- or CXCL7-stimulated GM-Mphis were higher than those of GM-Mphis without stimulation. These results indicate that both SPP1 and CXCL7 might have a role in the resistance against mycobacteria, at least in part, through augmenting reactive oxygen intermediate production in Mphis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16412049      PMCID: PMC1809597          DOI: 10.1111/j.1365-2249.2005.02985.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  45 in total

Review 1.  Osteopontin--a molecule for all seasons.

Authors:  M Mazzali; T Kipari; V Ophascharoensuk; J A Wesson; R Johnson; J Hughes
Journal:  QJM       Date:  2002-01

Review 2.  Mechanisms of phagocytosis in macrophages.

Authors:  A Aderem; D M Underhill
Journal:  Annu Rev Immunol       Date:  1999       Impact factor: 28.527

Review 3.  Microarray data normalization and transformation.

Authors:  John Quackenbush
Journal:  Nat Genet       Date:  2002-12       Impact factor: 38.330

Review 4.  How can immunology contribute to the control of tuberculosis?

Authors:  S H Kaufmann
Journal:  Nat Rev Immunol       Date:  2001-10       Impact factor: 53.106

5.  Genetic basis of patients with bacille Calmette-Guérin osteomyelitis in Japan: identification of dominant partial interferon-gamma receptor 1 deficiency as a predominant type.

Authors:  Yuka Sasaki; Akihiko Nomura; Koichi Kusuhara; Hidetoshi Takada; Saifuddin Ahmed; Kaoru Obinata; Keisuke Hamada; Yuri Okimoto; Toshiro Hara
Journal:  J Infect Dis       Date:  2002-02-14       Impact factor: 5.226

6.  High expression of platelet-derived growth factor and transforming growth factor-beta 1 in blast cells from patients with Down Syndrome suffering from transient myeloproliferative disorder and organ fibrosis.

Authors:  H Hattori; A Matsuzaki; A Suminoe; K Ihara; H Nakayama; T Hara
Journal:  Br J Haematol       Date:  2001-11       Impact factor: 6.998

Review 7.  Erasing the world's slow stain: strategies to beat multidrug-resistant tuberculosis.

Authors:  Christopher Dye; Brian G Williams; Marcos A Espinal; Mario C Raviglione
Journal:  Science       Date:  2002-03-15       Impact factor: 47.728

Review 8.  Functional heterogeneity of colony-stimulating factor-induced human monocyte-derived macrophages.

Authors:  Kiyoko S Akagawa
Journal:  Int J Hematol       Date:  2002-07       Impact factor: 2.490

9.  Interleukin-10, polymorphism in SLC11A1 (formerly NRAMP1), and susceptibility to tuberculosis.

Authors:  Agnes A Awomoyi; Arnaud Marchant; Joanna M M Howson; Keith P W J McAdam; Jenefer M Blackwell; Melanie J Newport
Journal:  J Infect Dis       Date:  2002-11-22       Impact factor: 5.226

Review 10.  Heterogeneity in the granulomatous response to mycobacterial infection in patients with defined genetic mutations in the interleukin 12-dependent interferon-gamma production pathway.

Authors:  David A Lammas; E De Heer; J D Edgar; V Novelli; A Ben-Smith; R Baretto; P Drysdale; J Binch; C MacLennan; D S Kumararatne; S Panchalingam; T H M Ottenhoff; J-L Casanova; J F Emile
Journal:  Int J Exp Pathol       Date:  2002-02       Impact factor: 1.925

View more
  8 in total

1.  Ipr1 Regulation by Cyclic GMP-AMP Synthase/Interferon Regulatory Factor 3 and Modulation of Irgm1 Expression via p53.

Authors:  Fayang Liu; Hongni Xue; Jie Ke; Yongyan Wu; Kezhen Yao; Shuxin Liang; Aihua Xu; Yong Zhang
Journal:  Mol Cell Biol       Date:  2020-03-30       Impact factor: 4.272

Review 2.  Platelet-derived chemokines: pathophysiology and therapeutic aspects.

Authors:  Hans-Dieter Flad; Ernst Brandt
Journal:  Cell Mol Life Sci       Date:  2010-03-07       Impact factor: 9.261

3.  Osteopontin is not crucial to protective immunity during murine tuberculosis.

Authors:  Gerritje J W van der Windt; Catharina W Wieland; Willem J Wiersinga; Sandrine Florquin; Tom van der Poll
Journal:  Immunology       Date:  2009-02-17       Impact factor: 7.397

4.  Lesion-Specific Immune Response in Granulomas of Patients with Pulmonary Tuberculosis: A Pilot Study.

Authors:  Selvakumar Subbian; Liana Tsenova; Mi-Jeong Kim; Helen C Wainwright; Annalie Visser; Nirmalya Bandyopadhyay; Joel S Bader; Petros C Karakousis; Gabriele B Murrmann; Linda-Gail Bekker; David G Russell; Gilla Kaplan
Journal:  PLoS One       Date:  2015-07-02       Impact factor: 3.240

5.  Comparative transcriptomic analysis of THP-1-derived macrophages infected with Mycobacterium tuberculosis H37Rv, H37Ra and BCG.

Authors:  Wenyuan Pu; Chen Zhao; Junaid Wazir; Zhonglan Su; Mengyuan Niu; Shiyu Song; Lulu Wei; Li Li; Xia Zhang; Xudong Shi; Hongwei Wang
Journal:  J Cell Mol Med       Date:  2021-10-10       Impact factor: 5.310

6.  Transcriptional profiling of mycobacterial antigen-induced responses in infants vaccinated with BCG at birth.

Authors:  Helen A Fletcher; Alana Keyser; Mark Bowmaker; Peter C Sayles; Gilla Kaplan; Greg Hussey; Adrian V S Hill; Willem A Hanekom
Journal:  BMC Med Genomics       Date:  2009-02-24       Impact factor: 3.063

7.  The pattern of cytokine production in vitro induced by ancient and modern Beijing Mycobacterium tuberculosis strains.

Authors:  Yih-Yuan Chen; Jia-Ru Chang; Wei-Feng Huang; Shu-Ching Hsu; Shu-Chen Kuo; Jun-Ren Sun; Horng-Yunn Dou
Journal:  PLoS One       Date:  2014-04-11       Impact factor: 3.240

8.  Review and Meta-Analyses of TAAR1 Expression in the Immune System and Cancers.

Authors:  Lisa M Fleischer; Rachana D Somaiya; Gregory M Miller
Journal:  Front Pharmacol       Date:  2018-06-26       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.